{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:06:16Z","timestamp":1779318376728,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>\n                    Im Kindes- und Jugendalter ist in \u00d6sterreich, im Gegensatz zum Erwachsenenalter, der Diabetes mellitus Typ\u00a01 (T1D) die am h\u00e4ufigsten auftretende Form des Diabetes mellitus\u00a0(94,2\u202f%). Nach der Diagnosestellung sollte die Betreuung der Kinder und Jugendlichen in einem p\u00e4diatrischen Zentrum mit viel Erfahrung in p\u00e4diatrischer Diabetologie erfolgen. Eine lebenslange Insulintherapie ist notwendig, wobei diese individuell an das Alter und den Alltag der Familie angepasst werden soll. In diesem Alter wird ausdr\u00fccklich die Verwendung von Diabetestechnologie (kontinuierliche Sensorglukosemessung, Insulinpumpentherapie und automatisierte Insulindosierung [AID]) empfohlen. Eine m\u00f6glichst optimale metabolische Einstellung ab Therapiebeginn verbessert die Langzeitprognose der jungen Menschen mit Diabetes. Ein wesentlicher Teil in der Betreuung ist die Schulung von jungen Menschen mit Diabetes und deren Erziehungsberechtigten von einem entsprechend ausgebildeten multidisziplin\u00e4ren Team, bestehend aus p\u00e4diatrischen DiabetologInnen, DiabetesberaterInnen, Di\u00e4tologInnen, PsychologInnen und SozialarbeiterInnen. Die APED\u00d6 (Arbeitsgruppe f\u00fcr p\u00e4diatrische Endokrinologie und Diabetologie \u00d6sterreich) und die ISPAD (International Society for Pediatric and Adolescent Diabetes) empfehlen als metabolisches Ziel f\u00fcr alle p\u00e4diatrischen Altersgruppen einen HbA\n                    <jats:sub>1c<\/jats:sub>\n                    -Wert\u202f\u2264\u20097,0\u202f% (IFCC\u202f\u2264\u200953\u202fmmol\/mol) bzw.\u202f\u2264\u20096,5 rel % (IFCC\u202f\u2264\u200948\u202fmmol\/mol) bei Verwendung von fortgeschrittener Diabetestechnologie wie AID mit einer \u201etime in range\u201c (TIR) &gt;\u202f70\u202f% ohne schwere Hypoglyk\u00e4mien. Eine altersentsprechend normale k\u00f6rperliche, kognitive und psychosoziale Entwicklung sowie die Vermeidung von Akutkomplikationen (schwere Hypoglyk\u00e4mien, diabetische Ketoazidose), das Screening auf assoziierte Erkrankungen und die Pr\u00e4vention von diabetesbedingten Sp\u00e4tkomplikationen zum Erhalt einer hohen Lebensqualit\u00e4t sind die Ziele der p\u00e4diatrischen Diabetestherapie.\n                  <\/jats:p>","DOI":"10.1007\/s00508-025-02650-3","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:15:43Z","timestamp":1779315343000},"page":"112-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetes mellitus im Kindes- und Jugendalter (Update 2026)","Diabetes mellitus in childhood and adolescence (Update 2026)"],"prefix":"10.1007","volume":"138","author":[{"given":"Birgit","family":"Rami-Merhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Fr\u00f6hlich-Reiterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine E.","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Meraner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Nagl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Fritsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"1","key":"2650_CR1","first-page":"S27","volume":"48","author":"NA ElSayed","year":"2025","unstructured":"ElSayed\u00a0NA, McCoy\u00a0RG, Aleppo\u00a0G, Balapattabi\u00a0K, Beverly\u00a0EA, Briggs Early\u00a0K, et\u00a0al. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142025. Diabetes Care. 2025;48(1):S27\u2013S49.","journal-title":"Diabetes Care"},{"issue":"8","key":"2650_CR2","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/pedi.13454","volume":"23","author":"I Libman","year":"2022","unstructured":"Libman\u00a0I, Haynes\u00a0A, Lyons\u00a0S, Pradeep\u00a0P, Rwagasor\u00a0E, Tung\u00a0JY, et\u00a0al. Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2022;23(8):1160\u201374.","journal-title":"Pediatr Diabetes"},{"key":"2650_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/4616903","volume":"2023","author":"K Nagl","year":"2023","unstructured":"Nagl\u00a0K, Waldh\u00f6r\u00a0T, Hofer\u00a0SE, Blauensteiner\u00a0N, Fritsch\u00a0M, Fr\u00f6hlich-Reiterer\u00a0E, et\u00a0al. Ongoing Increase in Incidence of Diabetes in Austrian Children and Adolescents (1989\u20132021): Results from a Nationwide Registry. Pediatr Diabetes. 2023;2023:1\u20137.","journal-title":"Pediatr Diabetes"},{"key":"2650_CR4","doi-asserted-by":"crossref","unstructured":"Nagl K, Waldh\u00f6r T, Hofer SE, Fritsch M, Meraner D, Prchla C, et\u00a0al. Alarming Increase of Ketoacidosis Prevalence at Type 1 Diabetes-Onset in Austria\u2014Results From a Nationwide Registry. Front Pediatr. 2022;10.","DOI":"10.3389\/fped.2022.820156"},{"key":"2650_CR5","doi-asserted-by":"publisher","first-page":"107842","DOI":"10.1016\/j.diabres.2019.107842","volume":"157","author":"CC Patterson","year":"2019","unstructured":"Patterson\u00a0CC, Karuranga\u00a0S, Salpea\u00a0P, Saeedi\u00a0P, Dahlquist\u00a0G, Soltesz\u00a0G, et\u00a0al. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107842.","journal-title":"Diabetes Res Clin Pract"},{"issue":"9680","key":"2650_CR6","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/S0140-6736(09)60568-7","volume":"373","author":"CC Patterson","year":"2009","unstructured":"Patterson\u00a0CC, Dahlquist\u00a0GG, Gy\u00fcr\u00fcs\u00a0E, Green\u00a0A, Solt\u00e9sz\u00a0G. Incidence trends for childhood type 1 diabetes in Europe during 1989\u20132003 and predicted new cases 2005\u201320: a multicentre prospective registration study. Lancet. 2009;373(9680):2027\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(09)60568-7.","journal-title":"Lancet"},{"issue":"6","key":"2650_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1159\/000543035","volume":"97","author":"MJ Haller","year":"2024","unstructured":"Haller\u00a0MJ, Bell\u00a0KJ, Besser\u00a0REJ, Casteels\u00a0K, Couper\u00a0JJ, Craig\u00a0ME, et\u00a0al. ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes. Horm Res Paediatr. 2024;97(6):529\u201345.","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"2650_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00608-021-00873-x","volume":"56","author":"B Rami-Merhar","year":"2021","unstructured":"Rami-Merhar\u00a0B, L\u00fcck\u00a0U, Fritsch\u00a0M, Fr\u00f6hlich-Reiterer\u00a0E, Hofer\u00a0SE. Struktur der Betreuung von Kindern und Jugendlichen mit Diabetes mellitus. Paediatr Paedolog. 2021;56(1):5\u20137.","journal-title":"Paediatr Paedolog"},{"key":"2650_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000543266","volume":"19","author":"M de Bock","year":"2024","unstructured":"de Bock\u00a0M, Agwu\u00a0JC, Deabreu\u00a0M, Dovc\u00a0K, Maahs\u00a0DM, Marcovecchio\u00a0ML, et\u00a0al. ISPAD Clinical Practice Consensus Guidelines 2024: Glycemic Targets. Horm Res Paediatr. 2024;19:1\u201313.","journal-title":"Horm Res Paediatr"},{"issue":"8","key":"2650_CR10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino\u00a0T, Danne\u00a0T, Bergenstal\u00a0RM, Amiel\u00a0SA, Beck\u00a0R, Biester\u00a0T, et\u00a0al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593\u2013603.","journal-title":"Diabetes Care"},{"issue":"3","key":"2650_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2337\/dc18-1444","volume":"42","author":"RW Beck","year":"2019","unstructured":"Beck\u00a0RW, Bergenstal\u00a0RM, Riddlesworth\u00a0TD, Kollman\u00a0C, Li\u00a0Z, Brown\u00a0AS, et\u00a0al. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care. 2019;42(3):400\u20135.","journal-title":"Diabetes Care"},{"issue":"5","key":"2650_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s11428-021-00769-1","volume":"17","author":"A Neu","year":"2021","unstructured":"Neu\u00a0A, B\u00fcrger-B\u00fcsing\u00a0J, Danne\u00a0T, Dost\u00a0A, Holder\u00a0M, Holl\u00a0RW, et\u00a0al. Diagnosis, therapy and follow-up of diabetes mellitus in children and adolescents. Diabetologe. 2021;17(5):557\u201384.","journal-title":"Diabetologe"},{"issue":"6","key":"2650_CR13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1159\/000543034","volume":"97","author":"T Biester","year":"2024","unstructured":"Biester\u00a0T, Berget\u00a0C, Boughton\u00a0C, Cudizio\u00a0L, Ekhlaspour\u00a0L, Hilliard\u00a0ME, et\u00a0al. International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies\u2014Insulin Delivery. Horm Res Paediatr. 2024;97(6):636\u201362.","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"2650_CR14","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jpeds.2014.07.001","volume":"165","author":"SE Hofer","year":"2014","unstructured":"Hofer\u00a0SE, Raile\u00a0K, Fr\u00f6hlich-Reiterer\u00a0E, Kapellen\u00a0T, Dost\u00a0A, Rosenbauer\u00a0J, Grulich-Henn\u00a0J, HRADPVDIGCN for DMellitus. Tracking of metabolic control from childhood to young adulthood in type 1 diabetes. J\u00a0Pediatr. 2014;165(5):956\u201361.","journal-title":"J Pediatr"},{"issue":"3","key":"2650_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/pedi.12085","volume":"15","author":"U Samuelsson","year":"2014","unstructured":"Samuelsson\u00a0U, Steineck\u00a0I, Gubbjornsdottir\u00a0S. A high mean-HbA1c value 3\u201315 months after diagnosis of type 1 diabetes in childhood is related to metabolic control, macroalbuminuria, and retinopathy in early adulthood\u2011a pilot study using two nation-wide population based quality registries. Pediatr Diabetes. 2014;15(3):229\u201335.","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"2650_CR16","first-page":"494","volume":"20","author":"V Mazarello Paes","year":"2019","unstructured":"Mazarello Paes\u00a0V, Barrett\u00a0JK, Taylor-Robinson\u00a0DC, Chesters\u00a0H, Charalampopoulos\u00a0D, Dunger\u00a0DB, et\u00a0al. Effect of early glycemic control on HbA1c tracking and development of vascular complications after 5 years of childhood onset type 1 diabetes: Systematic review and meta-analysis. Pediatr Diabetes. 2019;20(5):494\u2013509.","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"2650_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1159\/000543156","volume":"97","author":"M Tauschmann","year":"2025","unstructured":"Tauschmann\u00a0M, Cardona-Hernandez\u00a0R, DeSalvo\u00a0DJ, Hood\u00a0K, Laptev\u00a0DN, Lindholm Olinder\u00a0A, et\u00a0al. International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring. Horm Res Paediatr. 2025;97(6):615\u201335.","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"2650_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1159\/000543033","volume":"97","author":"AS Shah","year":"2024","unstructured":"Shah\u00a0AS, Barrientos-P\u00e9rez\u00a0M, Chang\u00a0N, Fu\u00a0JF, Hannon\u00a0TS, Kelsey\u00a0M, et\u00a0al. ISPAD Clinical Practice Consensus Guidelines 2024: Type 2 Diabetes in Children and Adolescents. Horm Res Paediatr. 2024;97(6):555\u201383.","journal-title":"Horm Res Paediatr"},{"key":"2650_CR19","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/pedi.13429","volume":"23","author":"SF Annan","year":"2022","unstructured":"Annan\u00a0SF, Higgins\u00a0LA, Jelleryd\u00a0E, Hannon\u00a0T, Rose\u00a0S, Salis\u00a0S, et\u00a0al. ISPAD Clinical Practice Consensus Guidelines 2022: Nutritional management in children and adolescents with diabetes. Pediatr Diabetes. 2022;23:1297\u2013321.","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"2650_CR20","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/pedi.13428","volume":"23","author":"M de Wit","year":"2022","unstructured":"de Wit\u00a0M, Gajewska\u00a0KA, Goethals\u00a0ER, McDarby\u00a0V, Zhao\u00a0X, Hapunda\u00a0G, et\u00a0al. ISPAD Clinical Practice Consensus Guidelines 2022: Psychological care of children, adolescents and young adults with diabetes. Pediatr Diabetes. 2022;23(8):1373\u201389.","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"2650_CR21","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/pedi.13443","volume":"23","author":"MB Abraham","year":"2022","unstructured":"Abraham\u00a0MB, Karges\u00a0B, Dovc\u00a0K, Naranjo\u00a0D, Arbelaez\u00a0AM, Mbogo\u00a0J, et\u00a0al. ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022;23(8):1322\u201340.","journal-title":"Pediatr Diabetes"},{"issue":"14","key":"2650_CR22","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jama.2017.13994","volume":"318","author":"B Karges","year":"2017","unstructured":"Karges\u00a0B, Schwandt\u00a0A, Heidtmann\u00a0B, Kordonouri\u00a0O, Binder\u00a0E, Schierloh\u00a0U, et\u00a0al. Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. Jama\u2014journal Am Med Assoc. 2017;318(14):1358\u201366.","journal-title":"Jama\u2014journal Am Med Assoc"},{"issue":"2","key":"2650_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S2213-8587(24)00284-5","volume":"13","author":"B Karges","year":"2025","unstructured":"Karges\u00a0B, Rosenbauer\u00a0J, Stahl-Pehe\u00a0A, Flury\u00a0M, Biester\u00a0T, Tauschmann\u00a0M, et\u00a0al. Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2\u201320 years) with type 1 diabetes: a population-based study. Lancet Diabetes Endocrinol. 2025;13(2):88\u201396.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"2650_CR24","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.2337\/dc18-2448","volume":"42","author":"A Haynes","year":"2019","unstructured":"Haynes\u00a0A, Hermann\u00a0JM, Clapin\u00a0H, Hofer\u00a0SE, Karges\u00a0B, Jones\u00a0TW, et\u00a0al. Decreasing Trends in Mean HbA1c Are Not Associated With Increasing Rates of Severe Hypoglycemia in Children: A Longitudinal Analysis of Two Contemporary Population-Based Pediatric Type 1 Diabetes Registries From Australia and Germany\/Austria Between 1995 and 2016. Diabetes Care. 2019;42(9):1630\u20136.","journal-title":"Diabetes Care"},{"issue":"7","key":"2650_CR25","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/pedi.13406","volume":"23","author":"N Glaser","year":"2022","unstructured":"Glaser\u00a0N, Fritsch\u00a0M, Priyambada\u00a0L, Rewers\u00a0A, Cherubini\u00a0V, Estrada\u00a0S, et\u00a0al. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022;23(7):835\u201356.","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"2650_CR26","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/pedi.13445","volume":"23","author":"E Fr\u00f6hlich-Reiterer","year":"2022","unstructured":"Fr\u00f6hlich-Reiterer\u00a0E, Elbarbary\u00a0NS, Simmons\u00a0K, Buckingham\u00a0B, Humayun\u00a0KN, Johannsen\u00a0J, et\u00a0al. ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2022;23(8):1451\u201367.","journal-title":"Pediatr Diabetes"},{"issue":"S1","key":"2650_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00608-021-00888-4","volume":"56","author":"E Fr\u00f6hlich-Reiterer","year":"2021","unstructured":"Fr\u00f6hlich-Reiterer\u00a0E, Hofer\u00a0S, Jasser-Nitsche\u00a0H, L\u00fcck\u00a0U, Rami-Merhar\u00a0B. Assoziierte Erkrankungen und andere Komplikationen. Paediatr Paedolog. 2021;56(S1):33\u20137.","journal-title":"Paediatr Paedolog"},{"issue":"8","key":"2650_CR28","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/pedi.13444","volume":"23","author":"P Bjornstad","year":"2022","unstructured":"Bjornstad\u00a0P, Dart\u00a0A, Donaghue\u00a0KC, Dost\u00a0A, Feldman\u00a0EL, Tan\u00a0GS, et\u00a0al. ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes. Pediatr Diabetes. 2022;23(8):1432\u201350.","journal-title":"Pediatr Diabetes"},{"issue":"S1","key":"2650_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00608-021-00889-3","volume":"56","author":"M Fritsch","year":"2021","unstructured":"Fritsch\u00a0M, Nagl\u00a0K, Rojacher\u00a0T, Dorninger\u00a0L, Hofer\u00a0S, Fr\u00f6hlich-Reiterer\u00a0E. Sp\u00e4tkomplikationen. Paediatr Paedolog. 2021;56(S1):38\u201342.","journal-title":"Paediatr Paedolog"},{"issue":"1","key":"2650_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MPG.0000000000002497","volume":"70","author":"S Husby","year":"2020","unstructured":"Husby\u00a0S, Koletzko\u00a0S, Korponay-Szab\u00f3\u00a0I, Kurppa\u00a0K, Mearin\u00a0ML, Ribes-Koninckx\u00a0C, et\u00a0al. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J\u00a0Pediatr Gastroenterol Nutr. 2020;70(1):141\u201356.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"2650_CR31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/pedi.13408","volume":"23","author":"JW Gregory","year":"2022","unstructured":"Gregory\u00a0JW, Cameron\u00a0FJ, Joshi\u00a0K, Eiswirth\u00a0M, Garrett\u00a0C, Garvey\u00a0K, et\u00a0al. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes in adolescence. Pediatr Diabetes. 2022;23(7):857\u201371.","journal-title":"Pediatr Diabetes"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02650-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-025-02650-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02650-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:15:44Z","timestamp":1779315344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-025-02650-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":31,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2650"],"URL":"https:\/\/doi.org\/10.1007\/s00508-025-02650-3","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.\u00a0Rami-Merhar hat in den letzten 36\u00a0Monaten von folgenden Firmen Honorare\/Forschungsgelder erhalten: Eli Lilly, Medtronic, Insulet, Abbott, Sanofi., E.\u00a0Fr\u00f6hlich-Reiterer hat in den letzten 36\u00a0Monaten von folgenden Firmen Vortragshonorare, Forschungsgelder und Honorare f\u00fcr Beratungst\u00e4tigkeit erhalten: Medtronic, Novo Nordisk, Eli Lilly, Sanofi und Merck., S.E.\u00a0Hofer erkl\u00e4rt in den letzten 3\u00a0Jahren Vortragshonorare der Firmen E. Lilly, Sanofi und Ypsomed erhalten zu haben., K.\u00a0Nagl hat in den letzten 26\u00a0Monaten von folgenden Firmen Honorare erhalten Eli Lilly, Sanofi., M.\u00a0Fritsch erkl\u00e4rt, in den letzten 3\u00a0Jahren Vortragshonorare der Firmen E.\u00a0Lilly, Sanofi und Rhythm Pharmaceuticals erhalten zu haben., D.\u00a0Meraner gibt an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}